MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s10238-023-01017-0

Медицинская библиотека · Clinical and experimental medicine · 2023

STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failure.

Solimando Antonio Giovanni, Desantis Vanessa, Palumbo Carmen, Marasco Carolina, Pappagallo Fabrizio, Montagnani Monica, Ingravallo Giuseppe, Cicco Sebastiano, Di Paola Rosa, Tabares Paula, Beilhack Andreas, Dammacco Franco, Ria Roberto, Vacca Angelo

Клинический случайСтатьяПеревод в очереди

Аннотация

We identified STAT1 gain of function (GOF) in a 32-year-old female with pallor, weakness, cough, and dyspnea admitted to our Division of Medicine. She had severe oral ulcers (OU), type 1 diabetes (T1DM), and pancytopenia. Bone marrow (BM) biopsy showed the absence of erythroid precursors. Peripheral blood parameters such as neutrophils < 500/mL, reticulocytes < 2%, and BM hypo-cellularity allowed to diagnose severe aplastic anemia. A heterozygous variant (p.520T>C, p.Cys174Arg) of STAT1 was uncovered. Thus, p.Cys174Arg mutation was investigated as potentially responsible for the patient's inborn immunity error and aplastic anemia. Although STAT1 GOF is rare, aplastic anemia is a more common condition; therefore, we explored STAT1 functional role in the pathobiology of BM failure. Interestingly, in a cohort of six patients with idiopathic aplastic anemia, enhanced phospho-STAT1 levels were observed on BM immunostaining. Next, the most remarkable features associated with STAT1 signaling dysregulation were examined: in both pure red cell aplasia and aplastic anemia, CD8+ T cell genetic variants and mutations display enhanced signaling activities related to the JAK-STAT pathway. Inborn errors of immunity may represent a paradigmatic condition to unravel crucial pathobiological mechanisms shared by common pathological conditions. Findings from our case-based approach and the phenotype correspondence to idiopathic aplastic anemia cases prompt further statistically powered prospective studies aiming to elucidate the exact role and theragnostic window for JAK/STAT targeting in this clinical context. Nonetheless, we demonstrate how a comprehensive study of patients with primary immunodeficiencies can lead to pathophysiologic insights and potential therapeutic approaches within a broader spectrum of aplastic anemia cases.

Для цитирования: Solimando Antonio Giovanni, Desantis Vanessa, Palumbo Carmen, Marasco Carolina, Pappagallo Fabrizio, Montagnani Monica, Ingravallo Giuseppe, Cicco Sebastiano, Di Paola Rosa, Tabares Paula, Beilhack Andreas, Dammacco Franco, Ria Roberto, Vacca Angelo. STAT1 overexpression triggers aplastic anemia: a pilot study unravelling novel pathogenetic insights in bone marrow failure.. Clinical and experimental medicine. 2023. DOI: 10.1007/s10238-023-01017-0.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.